|
(BS70) |
Palmitoleic Acid (C16:1) Regulates the AKT/FOXO- and ERK 1/2 Signaling Pathways in HL-1 Cardiomyocytes |
| |
|
S. Qaiyumi, I. Betz, S. Brix, A. Foryst-Ludwig, U. Kintscher (Berlin) |
|
(BS71) |
Palmitoleic acid induces dyssynchrony of cytosolic [Ca2+] release and prolongation of cytosolic [Ca2+] decline in rat ventricular myocytes |
| |
|
T. Guthof, A. Foryst-Ludwig, I. Betz, U. Kintscher, F. R. Heinzel (Berlin) |
|
(BS72) |
Glyoxalase 1 expression is regulated by Ca2+/calmodulin-dependent protein kinase II (CaMKII) and histone deacetylase 4 (HDAC4) |
| |
|
A. R. Saadatmand, V. Sramek, J. Chen, J. Backs, für die Studiengruppe: DZHK (Heidelberg) |
|
(BS73) |
Metabolomics in Translational Medicine –A Link between Acylcarnitines and Atrial Fibrillation |
| |
|
J. Krause, A. Löser, D. Börnigen, R. Schnabel, S. Blankenberg, T. Eschenhagen, J. Stenzig, T. Zeller (Hamburg) |
|
(BS74) |
Desmoglein 2 mutation induces regional overexpression of the
glucose transporter 1 |
| |
|
F. Bruns, S. Kant, R. Leube, C. Krusche (Aachen) |
|
(BS75) |
Redox Regulation of Engineered Heart Muscle Function |
| |
|
I. Eckhardt, E. Heta, P. L. Soong, W.-H. Zimmermann, H. Gothe, für die Studiengruppe: DZHK (Göttingen, Berlin) |